HNDFDS Hindustan Foods Q2 FY25 results (Jul–Sep 2024) and concall
Hindustan Foods reported robust top-line growth in Q2 and H1 FY25, driven by the expansion of its shoe business and scaling of the OTC Health and Wellness factory in Baddi. While revenues increased smartly, overall profitability was flat due to additional costs associated with the integration of the shoe business. The company is actively diversifying into high-growth avenues like ice cream, beverages, and footwear, with significant capex planned for new facilities and capacity expansions, aiming for a gross block of over ₹1,800 crores by FY26.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 |
|---|---|
| Revenue | 883 |
| EBITDA | 70 |
| Net profit | 23 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
